MSH|^~\&||SMH|||201911251421||ORM^O01|4112497|D|2.3|||AL|NE
PID|1||SM00043832|SM43675|MITEST^SMH^CLINICALLONGNAME^^^^L||19670504|F||||||||||SM004667/18|9875611239
PV1|1|O
ORC|SC|CT20190613-0004SMH|||R
OBR|1|CT20190613-0004SMH||CT^CHC^Chest Contrast||20190613|201906131544|201906131544|||||||||||||||||||||||MIREASON^RFE TESTING
OBX|1|TX|ADM CC #^BCCA Client #||^90705040
OBX|2|TX|MICANRES^Canadian Resident?||^Y
OBX|3|TX|MICOMMENT^Comment:||^CMT TESTING
OBX|4|TX|MICOPIES^Total # of Copies to:||^1
OBX|5|CE|MICTPRIOE^Priority:||P2^Within 7 days^CT PRIORITY OE
OBX|6|TX|MIPTREQDEL^Pt-Related Delay?||^N
OBX|7|CE|MIPTTYPE^Pt Type:||O^OUT PATIENT or OTHER HOSP^PATIENT TYPE
OBX|8|TX|MIREASON^Reason for Exam:||^RFE TESTING
OBX|9|TX|MIREASON2^Pertinent History:||^PH TESTING
OBX|10|TX|MIREQDATE^Date Req Rec'd:||^20190613
OBX|11|TX|MIRESIDENT^NRC Agreement Signed?||^N
OBX|12|TX|MITRANS^Transportation:||^Ambulatory
OBX|13|CE|OEISO^Infection Control:||S^Standard/Routine^Isolation Responses